{"id":"https://openalex.org/W2526623935","doi":null,"title":"Potentieel letale nevenwerkingen van clozapine en verpleegkundige aandachtspunten: een review","display_name":"Potentieel letale nevenwerkingen van clozapine en verpleegkundige aandachtspunten: een review","publication_year":2013,"publication_date":"2013-03-01","ids":{"openalex":"https://openalex.org/W2526623935","mag":"2526623935"},"language":"nl","primary_location":{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/412818","doi":null,"is_oa":true,"landing_page_url":"https://lirias.kuleuven.be/handle/123456789/412818","pdf_url":"https://lirias.kuleuven.be/bitstream/123456789/412818/2/de%20beugher%20de%20hert%20BVL_PV_2013-03%20artikel%20clozapine%20psy%20vp%202013.pdf","source":{"id":"https://openalex.org/S7407055369","display_name":"Lirias","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Psychiatrie en Verpleging, vol. 3, (101-114)","raw_type":"info:eu-repo/semantics/article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://lirias.kuleuven.be/bitstream/123456789/412818/2/de%20beugher%20de%20hert%20BVL_PV_2013-03%20artikel%20clozapine%20psy%20vp%202013.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041921029","display_name":"Annelien De Beugher","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Annelien De Beugher","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5105570407","display_name":"Marc D. Binder","orcid":"https://orcid.org/0000-0003-4255-5920","observed_orcids":["https://orcid.org/0000-0003-4255-5920"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marc D. Binder","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4255-5920","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1982,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.55363222,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"3","issue":null,"first_page":"101","last_page":"114"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10508","display_name":"Patient Safety and Medication Errors","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clozapine-adverse-effects","display_name":"clozapine adverse effects","score":0.800000011920929},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8270000219345093},{"id":"https://openalex.org/keywords/treatment-resistant-schizophrenia","display_name":"treatment-resistant schizophrenia","score":0.7639999985694885},{"id":"https://openalex.org/keywords/nursing-care","display_name":"nursing care","score":0.5230000019073486},{"id":"https://openalex.org/keywords/tardive-dyskinesia","display_name":"tardive dyskinesia","score":0.8289999961853027},{"id":"https://openalex.org/keywords/parkinsonism","display_name":"parkinsonism","score":0.7310000061988831},{"id":"https://openalex.org/keywords/dystonia","display_name":"dystonia","score":0.7929999828338623},{"id":"https://openalex.org/keywords/antipsychotic-induced-parkinsonism","display_name":"antipsychotic-induced parkinsonism","score":0.9480000138282776}],"concepts":[{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.5187709331512451},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4084986448287964},{"id":"https://openalex.org/C142362112","wikidata":"https://www.wikidata.org/wiki/Q735","display_name":"Art","level":0,"score":0.35406917333602905},{"id":"https://openalex.org/C27206212","wikidata":"https://www.wikidata.org/wiki/Q34178","display_name":"Theology","level":1,"score":0.34818896651268005},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3447626829147339},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.13101887702941895},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.09433981776237488},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0862669050693512}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/412818","doi":null,"is_oa":true,"landing_page_url":"https://lirias.kuleuven.be/handle/123456789/412818","pdf_url":"https://lirias.kuleuven.be/bitstream/123456789/412818/2/de%20beugher%20de%20hert%20BVL_PV_2013-03%20artikel%20clozapine%20psy%20vp%202013.pdf","source":{"id":"https://openalex.org/S7407055369","display_name":"Lirias","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Psychiatrie en Verpleging, vol. 3, (101-114)","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:2526623935","doi":null,"is_oa":false,"landing_page_url":"https://lirias.kuleuven.be/bitstream/123456789/412818/2/de+beugher+de+hert+BVL_PV_2013-03+artikel+clozapine+psy+vp+2013.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/412818","doi":null,"is_oa":true,"landing_page_url":"https://lirias.kuleuven.be/handle/123456789/412818","pdf_url":"https://lirias.kuleuven.be/bitstream/123456789/412818/2/de%20beugher%20de%20hert%20BVL_PV_2013-03%20artikel%20clozapine%20psy%20vp%202013.pdf","source":{"id":"https://openalex.org/S7407055369","display_name":"Lirias","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Psychiatrie en Verpleging, vol. 3, (101-114)","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2526623935.pdf","grobid_xml":"https://content.openalex.org/works/W2526623935.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W30928844","https://openalex.org/W108684976","https://openalex.org/W1567867011","https://openalex.org/W1701339540","https://openalex.org/W1828019950","https://openalex.org/W1993446055","https://openalex.org/W2055815712","https://openalex.org/W2058181488","https://openalex.org/W2062728944","https://openalex.org/W2072993766","https://openalex.org/W2085360366","https://openalex.org/W2089671853","https://openalex.org/W2111844929","https://openalex.org/W2114258247","https://openalex.org/W2117209734","https://openalex.org/W2123186700","https://openalex.org/W2139078690","https://openalex.org/W2152109892","https://openalex.org/W2154820798","https://openalex.org/W2157467185","https://openalex.org/W2164820589","https://openalex.org/W2168985903","https://openalex.org/W2168991266","https://openalex.org/W2170000130","https://openalex.org/W2278560175"],"related_works":["https://openalex.org/W4301153825","https://openalex.org/W2415394151","https://openalex.org/W4300184735","https://openalex.org/W4416277518","https://openalex.org/W2460927735","https://openalex.org/W2418912352","https://openalex.org/W2421875048","https://openalex.org/W7167289350","https://openalex.org/W4214536154","https://openalex.org/W4301625355"],"abstract_inverted_index":{"Potentieel":[0],"letale":[1],"nevenwerkingen":[2,178],"van":[3,23,34,53,80,92,96,132,148,171,226],"clozapine":[4,172,193,219],"en":[5,26,85,183],"verpleegkundige":[6],"aandachtspunten:":[7],"een":[8,10,14,112,141],"reviewClozapine,":[9],"tricyclisch":[11],"dibenzodiazepine,":[12],"is":[13,58],"atypisch":[15],"antipsychoticum":[16],"dat":[17,70,86],"gebruikt":[18],"wordt":[19],"in":[20,102],"de":[21,32,54,74,103,149],"behandeling":[22,93,142,217],"therapieresistente":[24],"schizofrenie":[25,57,153],"bij":[27,29],"psychosen":[28],"pati\u00ebnten":[30,55,72,88,150],"met":[31,56,94,111,152,218],"ziekte":[33],"Parkinson":[35],"waarbij":[36],"standaard":[37,158],"medicatie":[38],"geen":[39,78,107],"effect":[40],"heeft":[41],"of":[42,160],"veel":[43],"motorische":[44,177],"neveneffecten":[45,162],"induceert":[46],"(Schulte,":[47],"2006;":[48,202],"Merrill":[49],"e.a.,":[50,124,165,190,200,204],"2005).Ongeveer":[51],"20%":[52],"therapieresistent.In":[59],"1988":[60],"werden":[61],"2":[62,98],"criteria":[63],"voor":[64],"therapieresistentie":[65],"opgesteld":[66],"door":[67],"Kane,":[68],"namelijk":[69],"(1)":[71],"gedurende":[73,120],"afgelopen":[75],"5":[76,105],"jaar":[77,106],"periodes":[79,91],"goed":[81],"functioneren":[82],"hadden":[83],"ervaren":[84,163],"(2)":[87],"na":[89],"3":[90],"neuroleptica":[95],"t":[97],"verschillende":[99],"chemische":[100],"klassen":[101],"voorbije":[104],"significante":[108],"verbetering":[109],"ervoeren":[110],"dosisequivalent":[113],"aan":[114,136,143],"1000":[115],"mg":[116],"chloorprozamine":[117],"per":[118],"dag":[119],"6":[121],"weken":[122],"(Kane":[123],"1988;Conley":[125],"&":[126,129,186],"Buchanan,":[127],"1997;Kerwin":[128],"Bolonna,":[130],"2005).Tal":[131],"voordelen":[133],"zijn":[134],"gekoppeld":[135],"clozapine.Ten":[137],"eerste":[138],"biedt":[139],"het":[140,169,195,224],"ongeveer":[144],"10%":[145],"tot":[146,176,210,223],"50%":[147],"gediagnosticeerd":[151],"die":[154,213],"niet":[155],"reageren":[156],"op":[157,197],"antipsychotica":[159],"ernstige":[161,211],"(Merrill":[164],"2005).Ten":[166],"tweede":[167],"geeft":[168],"gebruik":[170],"uiterst":[173],"zelden":[174],"aanleiding":[175,208,221],"zoals":[179],"tardieve":[180],"dyskinesie,":[181],"dystonie":[182],"parkinsonisme":[184],"(Alvir":[185],"Lieberman,":[187],"1994;":[188],"Tandon":[189,203],"2010).Verder":[191],"vermindert":[192],"sterk":[194],"risico":[196],"su\u00efcidaliteit":[198],"(Meltzer":[199],"2003;Schulte,":[201],"2010).Clozapine":[205],"kan":[206,220],"echter":[207],"geven":[209,222],"complicaties":[212],"letaal":[214],"kunnen":[215],"zijn.Een":[216],"ontstaan":[225],"agranulocytose":[227],"(Asenjo":[228],"Lobos":[229],"e.a.":[230]},"counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-10-07T00:00:00"}